Single-blind, Partially Randomised, Placebo-controlled Phase I Study to Investigate Safety, Tolerability and Pharmacokinetics of Single Rising Intravenous Doses of BI 655130 in Healthy Male Volunteers

Trial Profile

Single-blind, Partially Randomised, Placebo-controlled Phase I Study to Investigate Safety, Tolerability and Pharmacokinetics of Single Rising Intravenous Doses of BI 655130 in Healthy Male Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Jun 2016

At a glance

  • Drugs BI 655130 (Primary)
  • Indications Unspecified
  • Focus Adverse reactions
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 08 Jun 2016 Status changed from active, no longer recruiting to completed.
    • 11 Apr 2016 Status changed from recruiting to active, no longer recruiting.
    • 04 Mar 2016 Number of arms changed from one to two and study design changed to single group assignment to parallel and randomized as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top